share_log

Takeda Pharmaceutical | 6-K: Announcement of a company split (simplified absorption-type company split/short-form company split) with a wholly-owned subsidiary

SEC announcement ·  Jan 16 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more